SCHEMBL25075681

SCHEMBL25075681

CC(=O)N1CC2(CCCO2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
CNR2 P34972 1/20 0.34
CYP1A2 P05177 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP2C19 P33261 2/20 0.31
CYP3A4 P08684 2/20 0.31
HIF1A Q16665 2/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPK1 P28482 1/20 0.31
VNN1 O95497 2/20 0.31
EPHX2 P34913 1/20 0.31
KCNH2 Q12809 1/20 0.31
MCHR1 Q99705 1/20 0.31
MGLL Q99685 1/20 0.31
OPRK1 P41145 2/20 0.30
CYP2D6 P10635 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30327242 0.89 SMN1; SMN2 (0.45) NAMPTSMN1; SMN2CYP1A2TDP1CYP2C19
SCHEMBL15750499 0.86 CYP3A4 (0.40) NAMPTSMN1; SMN2HDAC1HDAC2CYP1A2
SCHEMBL29975368 0.83 NAMPT (0.41) NAMPTHDAC1HDAC2CNR2CYP3A4
SCHEMBL29626816 0.82 NAMPT (0.40) NAMPTHDAC1HDAC2CNR2VNN1
SCHEMBL13010322 0.82 SMN1; SMN2 (0.47) SMN1; SMN2HDAC1HDAC2CYP1A2TDP1
SCHEMBL25629294 0.81 NAMPT (0.38) NAMPTHDAC1HDAC2CNR2VNN1
SCHEMBL29619703 0.79 NAMPT (0.44) NAMPTHDAC1HDAC2CNR2VNN1
SCHEMBL2960736 0.77 USP2 (0.47) NAMPTSMN1; SMN2EPHX2MEN1KMT2A
SCHEMBL18478531 0.75 SMN1; SMN2 (0.48) SMN1; SMN2CYP1A2TDP1CYP2C19ALDH1A1
SCHEMBL18478131 0.75 SMN1; SMN2 (0.43) SMN1; SMN2HDAC1HDAC2CYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098825-A1 SOS1 INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 勤浩医药(苏州)有限公司 2023-06-08 WO disclosed
WO-2023023631-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-02-23 WO disclosed